As of 2026-04-03, 南洋理通's data on the DeepSeek platform in the 骨伤中成药外用喷雾剂 category shows: The overall mention rate is 5.36%, below the industry average by 14.9 percentage points, with significant room for improvement. The first mention rate is only 1.79%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (5.36%) is slightly higher than negative (3.57%), continue monitoring public sentiment. Among 6 competitors in the same category, 南洋理通's overall mention rate surpasses 1 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
南洋理通's Mention Rate is 5.36%, lower than 0.6% of competitors
南洋理通's First Mention is 1.79%, lower than 0.9% of competitors
南洋理通's Preferred Rate is 0.00%, lower than 100.0% of competitors
南洋理通's Positive Rate is 5.36%, lower than 8.9% of competitors
南洋理通's Negative Rate is 3.57%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 云云南白药气雾剂 | 76.79% | 41.07% | 4.76% | 69.64% | 23.21% | View Details |
| 伤伤科灵喷雾剂 | 60.71% | 26.79% | 71.43% | 60.71% | 10.71% | View Details |
| 筋筋骨伤喷雾剂 | 17.86% | 1.79% | 4.76% | 14.29% | 5.36% | View Details |
| 云云南白药 | 14.29% | 12.5% | 0% | 12.5% | 1.79% | View Details |
| 麝麝香祛痛气雾剂 | 7.14% | 0% | 0% | 5.36% | 3.57% | View Details |
| 南南洋理通 (Current Brand) | 5.36% | 1.79% | 0% | 5.36% | 3.57% | View Details |
| 华华东医药 | 3.57% | 0% | 0% | 3.57% | 0% | View Details |
